Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$98.98 - $115.74 $255,764 - $299,072
2,584 Added 3.29%
81,114 $9.38 Million
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $4.58 Million - $5.34 Million
-47,500 Reduced 37.69%
78,530 $8.08 Million
Q1 2023

May 11, 2023

BUY
$107.32 - $113.5 $9.25 Million - $9.78 Million
86,209 Added 216.49%
126,030 $13.8 Million
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $2.48 Million - $4.53 Million
39,821 New
39,821 $4.53 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Chicago Capital Management, LLC Portfolio

Follow Chicago Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital Management, LLC with notifications on news.